Literature DB >> 8285812

Smoking cessation and time course of decreased risks of coronary heart disease in middle-aged women.

I Kawachi1, G A Colditz, M J Stampfer, W C Willett, J E Manson, B Rosner, F E Speizer, C H Hennekens.   

Abstract

BACKGROUND: We examined prospectively the relation of time since stopping smoking with risk of coronary heart disease in middle-aged women.
METHODS: The study was based on 12 years' follow-up data (1976 through 1988) from the Nurses' Health Study, an ongoing prospective cohort study, in which information on smoking habits was updated every 2 years by a mailed questionnaire. The study population consisted of 117,006 female registered nurses aged 30 to 55 years in 1976 who were free of coronary heart disease, stroke, and cancer at baseline. The outcome measure used was incident coronary heart disease, defined as nonfatal myocardial infarction plus fatal coronary heart disease.
RESULTS: A total of 970 incident cases of coronary heart disease (215 among participants who never smoked, 214 among former smokers, and 541 among current smokers) occurred during 1.37 million person-years of follow-up. The multivariate relative risk of total coronary heart disease among current smokers compared with participants who never smoked was 4.23 (95% confidence interval, 3.60 to 4.96). Risk of coronary heart disease was highest among smokers who started smoking before the age of 15 years (relative risk, 9.25; 95% confidence interval, 5.27 to 16.23). The relative risk among former smokers was 1.48 (95% confidence interval, 1.22 to 1.79). On stopping smoking, one third of the excess risk of coronary heart disease was eliminated within 2 years of cessation. Thereafter, the excess risk returned to the level of those who never smoked during the interval 10 to 14 years following cessation.
CONCLUSION: Women who stop smoking will experience an immediate benefit as well as a further longer-term decline in excess risk of coronary heart disease to the level of those who never smoked.

Entities:  

Mesh:

Year:  1994        PMID: 8285812

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  53 in total

1.  Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association.

Authors: 
Journal:  Heart       Date:  1998-12       Impact factor: 5.994

2.  Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trial.

Authors:  Alan R Lifson; Jacqueline Neuhaus; Jose Ramon Arribas; Mary van den Berg-Wolf; Ann M Labriola; Timothy R H Read
Journal:  Am J Public Health       Date:  2010-08-19       Impact factor: 9.308

Review 3.  A clinical prescription for heart health in midlife women.

Authors:  Chrisandra Shufelt; Erika Dutra; Tina Torbati; Tina Ramineni
Journal:  Maturitas       Date:  2018-11-12       Impact factor: 4.342

4.  JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.

Authors: 
Journal:  Heart       Date:  2005-12       Impact factor: 5.994

5.  Associations of Cigarettes Smoked Per Day with Biomarkers of Exposure Among U.S. Adult Cigarette Smokers in the Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014).

Authors:  Brian L Rostron; Catherine G Corey; Joanne T Chang; Dana M van Bemmel; Mollie E Miller; Cindy M Chang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-06-25       Impact factor: 4.254

6.  The natural history of light smokers: a population-based cohort study.

Authors:  Douglas E Levy; Lois Biener; Nancy A Rigotti
Journal:  Nicotine Tob Res       Date:  2009-03-05       Impact factor: 4.244

7.  Association of Smoking Cessation With Subsequent Risk of Cardiovascular Disease.

Authors:  Meredith S Duncan; Matthew S Freiberg; Robert A Greevy; Suman Kundu; Ramachandran S Vasan; Hilary A Tindle
Journal:  JAMA       Date:  2019-08-20       Impact factor: 56.272

8.  Criteria for the evaluation of large cohort studies: an application to the nurses' health study.

Authors:  Graham A Colditz; Deborah M Winn
Journal:  J Natl Cancer Inst       Date:  2008-06-24       Impact factor: 13.506

Review 9.  Symbiotic relationship of pharmacogenetics and drugs of abuse.

Authors:  Joni L Rutter
Journal:  AAPS J       Date:  2006-03-24       Impact factor: 4.009

10.  Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men.

Authors:  Michel M Joosten; Jennifer K Pai; Monica L Bertoia; Eric B Rimm; Donna Spiegelman; Murray A Mittleman; Kenneth J Mukamal
Journal:  JAMA       Date:  2012-10-24       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.